Background

The question of anticoagulant dosing in hospitalized patients with coronavirus disease-2019 (COVID-19) is unresolved, with randomized trials showing mixed results and heterogeneity of treatment effects for in-hospital death.

Objective

To examine the association between the intensity of anticoagulation and clinical outcomes in hospitalized patients with COVID-19.

Matéria original

Anterior

Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review

Próxima

Potential influence of COVID-19 and dexamethasone on the reproductive system: what we know and can expect